Healthcare provider profile · identity verified

Stephen M Rogers, MD

Internal Medicine · EAU CLAIRE, WI · NPI 1538149711

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	424	143
Levothyroxine Sodium	Levothyroxine Sodium	304	94
Amlodipine Besylate	Amlodipine Besylate	276	96
Lisinopril	Lisinopril	228	70
Metoprolol Succinate	Metoprolol Succinate	204	62
Eliquis	Apixaban	188	44
Warfarin Sodium	Warfarin Sodium	187	22
Losartan Potassium	Losartan Potassium	170	61
Omeprazole	Omeprazole	158	54
Furosemide	Furosemide	154	59
Metoprolol Tartrate	Metoprolol Tartrate	151	49
Simvastatin	Simvastatin	147	51
Pantoprazole Sodium	Pantoprazole Sodium	145	47
Atenolol	Atenolol	134	35
Potassium Chloride	Potassium Chloride	123	44
Tramadol Hcl	Tramadol Hcl	118	36
Alprazolam	Alprazolam	115	37
Metformin Hcl Er	Metformin Hcl	115	36
Hydrochlorothiazide	Hydrochlorothiazide	114	44
Tamsulosin Hcl	Tamsulosin Hcl	106	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	105	36
Sertraline Hcl	Sertraline Hcl	102	39
Rosuvastatin Calcium	Rosuvastatin Calcium	101	33
Mirtazapine	Mirtazapine	99	31
Gabapentin	Gabapentin	87	31
Trazodone Hcl	Trazodone Hcl	79	28
Allopurinol	Allopurinol	78	26
Fluoxetine Hcl	Fluoxetine Hcl	74	24
Pravastatin Sodium	Pravastatin Sodium	69	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	69	20
Clopidogrel	Clopidogrel Bisulfate	68	23
Famotidine	Famotidine	62	21
Glipizide	Glipizide	62	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	24
Alendronate Sodium	Alendronate Sodium	51	19
Albuterol Sulfate Hfa	Albuterol Sulfate	50	24
Duloxetine Hcl	Duloxetine Hcl	47	17
Fluticasone Propionate	Fluticasone Propionate	46	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	44	12
Lorazepam	Lorazepam	44	16
Metformin Hcl	Metformin Hcl	42	14
Zolpidem Tartrate	Zolpidem Tartrate	42	13
Prednisone	Prednisone	41	27
Doxazosin Mesylate	Doxazosin Mesylate	39	13
Meloxicam	Meloxicam	38	12
Pregabalin	Pregabalin	38	suppressed
Spironolactone	Spironolactone	38	12
Triamcinolone Acetonide	Triamcinolone Acetonide	38	18
Escitalopram Oxalate	Escitalopram Oxalate	36	suppressed
Buspirone Hcl	Buspirone Hcl	35	suppressed
Xarelto	Rivaroxaban	35	11
Trulicity	Dulaglutide	33	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Acyclovir	Acyclovir	29	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Methylprednisolone	Methylprednisolone	29	22
Torsemide	Torsemide	28	suppressed
Estradiol	Estradiol	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Ozempic	Semaglutide	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Clonazepam	Clonazepam	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Finasteride	Finasteride	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Diazepam	Diazepam	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Fentanyl	Fentanyl	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Azithromycin	Azithromycin	19	18
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	15
Enoxaparin Sodium	Enoxaparin Sodium	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Glimepiride	Glimepiride	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Amoxicillin	Amoxicillin	16	15
Oxycontin	Oxycodone Hcl	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	15	suppressed
Carvedilol	Carvedilol	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error